REVENUE MEMORANDUM CIRCULAR NO. 138-2022 issued on October 17, 2022 circularizes the List of BIR Official Social Media Accounts being managed by the Primary Social Media Team and Sub-Social Media Teams of the BIR, to wit:

REVENUE MEMORANDUM CIRCULAR NO. 137-2022 issued on October 14, 2022 further clarifies the guidelines on the availment of VAT Zero Rate (0%) on Health Maintenance Organization (HMO) Plans acquired by Registered Export Enterprises (REEs) and

REVENUE MEMORANDUM CIRCULAR NO. 136-2022 issued on October 14, 2022 publishes Fiscal Incentives Review Board (FIRB) Resolution No. 026-2022 extending the 70:30 Work-From-Home (WFH) arrangement for Registered Business Enterprises (RBEs) in the Information Technology Business Process

REVENUE MEMORANDUM CIRCULAR NO. 135-2022 issued on October 12, 2022 prescribes the standards of Completed Staff Work (CSW) for all documents to be submitted to the Office of the Commissioner for approval.         

REVENUE MEMORANDUM CIRCULAR NO. 134-2022 issued on October 7, 2022 notifies the loss of two (2) sets of unused BIR Form No. 0535 – Taxpayer Information Sheet (TIS) bearing the following Serial Numbers: Serial Number No.

REVENUE MEMORANDUM CIRCULAR NO.133-2022 issued on October 6, 2022 circularizes the Consolidated Price of Sugar at Millsite for the month of August 2022 contained in Operations Memorandum (OM) Nos. 68-2022, 69-2022, 70-2022 and 71-2022.     

REVENUE MEMORANDUM CIRCULAR NO. 132-2022 issued on September 29, 2022 enjoins all BIR officials and employees to participate in the celebration of the 33rd National Statistics Month (NSM) in October 2022 with the theme “Boosting the

REVENUE MEMORANDUM CIRCULAR NO. 131-2022 issued on September 28, 2022 announces the availability of Offline Electronic Bureau of Internal Revenue Forms (eBIRForms) Package Version 7.9.3, which is downloadable from www.bir.gov.ph and www.knowyourtaxes.ph/ebirforms.         

REVENUE MEMORANDUM CIRCULAR NO. 130-2022 issued on September 26, 2022 extends until September 27, 2022 the deadline for the eFiling/filing of returns (BIR Forms 2550M, 2550Q and 2551Q) and ePayment/payment of corresponding taxes due thereon as

REVENUE MEMORANDUM CIRCULAR NO. 129-2022 issued on September 20, 2022 publishes the September 1, 2022 letter from Food and Drug Administration (FDA) Director General Samuel A. Zacate endorsing updates to the “List of VAT-Exempt Medicines” under